Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $382.7 million.

  • Fresenius Medical Care AG's Profit After Tax rose 3199.52% to $382.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $981.4 million, marking a year-over-year increase of 297.17%. This contributed to the annual value of $791.8 million for FY2024, which is 53.85% up from last year.
  • Fresenius Medical Care AG's Profit After Tax amounted to $382.7 million in Q3 2025, which was up 3199.52% from $308.2 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Profit After Tax ranged from a high of $854.1 million in Q1 2025 and a low of $574811.3 during Q4 2024
  • Over the past 5 years, Fresenius Medical Care AG's median Profit After Tax value was $259.5 million (recorded in 2024), while the average stood at $252.2 million.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Profit After Tax soared by 3999093.69% in 2023, and later crashed by 9979.13% in 2024.
  • Over the past 5 years, Fresenius Medical Care AG's Profit After Tax (Quarter) stood at $1.1 million in 2021, then plummeted by 38.04% to $687039.6 in 2022, then soared by 39990.94% to $275.4 million in 2023, then plummeted by 99.79% to $574811.3 in 2024, then surged by 66475.24% to $382.7 million in 2025.
  • Its Profit After Tax was $382.7 million in Q3 2025, compared to $308.2 million in Q2 2025 and $854.1 million in Q1 2025.